"$2B / 5 equals avg of 400M per year. Apply that with a PE of 10 gives a market cap 4B."
That is indeed one conservative PE ratio - the average for the biotech industry on the ASX is 46 which on the 'lower side' of that average is CSL with a PE of 37, so that's your conservative base case. For contrast, Telix has a PE of 124. Pretty much pick any number well north of 50 for the PE for any ASX biotech that gets their first drug to market.
- Forums
- ASX - By Stock
- Ann: Security Class Reinstatement to Quotation- OPTOB
"$2B / 5 equals avg of 400M per year. Apply that with a PE of 10...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
59.5¢ |
Change
-0.015(2.46%) |
Mkt cap ! $732.5M |
Open | High | Low | Value | Volume |
60.0¢ | 61.0¢ | 59.0¢ | $11.30M | 18.98M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 45916 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 45916 | 0.590 |
2 | 37273 | 0.585 |
3 | 38706 | 0.580 |
2 | 108695 | 0.575 |
3 | 44061 | 0.570 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 10000 | 1 |
0.605 | 47182 | 2 |
0.610 | 42308 | 4 |
0.615 | 1600 | 1 |
0.620 | 130700 | 4 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |